Institut fuer Diabetesforschung Muenster GmbH — Clinical Trial Site

38 Registered trials

11 Currently recruiting

Organisation

Institut fuer Diabetesforschung Muenster GmbH

Location

Muenster, Germany

Identifier

ORG-100040196

Address

Hohenzollernring 70, Herz-Jesu, 48145, Germany

Departments

-
#2116
2211: Institut für Diabetesforschung Münster GmbH
IDFM
IDFM GmbH
Innere Medizin, Angiologie & Diabetologie, Ernährungsmedizin
Institut für Diabetesforschung
Institut für Diabetesforschung im Franziskus Carré Münster GmbH
Institut für Diabetesforschung Münster GmbH
internal medicine, diabetology
N/A
NA
private practice
Zentrum für Diabetes und Gefäßerkrankungen im Franziskus Carré

Clinical trials at this site (38)

Search interface

A weight loss study evaluating subcutaneous treatment withAZD9550 and AZD6234 in combination, against placebo or each of the drugs alone Ended

2024-516176-15-00 Investigating obesity or overweight condition correlate 4 2025-02-24
Effects of AZD5004 in adults who are living with obesity or overweight with at least 1 weight-related medical condition Ended

2024-513691-18-00 Participants living with Obesity or Overweight with at 4 2024-12-11
A research study to see how well different doses of CagriSema help people with excess body weight lose weight Ended

2023-509273-24-00 Obesity 5 2024-09-05
A research study comparing how well different doses of the medicine NNC0487-0111 lower blood sugar in people with type 2 diabetes Ended

2023-509412-28-00 Type 2 Diabetes 4 2024-07-26
A Research Study to See How Switching from a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar … Ended

2023-506084-34-00 Type 2 Diabetes 5 2024-04-12
A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control W… Ended

2023-507206-13-00 Type 2 Diabetes 5 2024-03-14
A study to test whether BI 456906 helps people living with overweight or obesity who do not have diabetes to lose weight Ended

2022-502529-17-00 Obesity 5 2024-01-18
A study to test whether BI 456906 helps people living with overweight or obesity who also have diabetes to lose weight Ended

2022-502531-18-00 Obesity 5 2024-01-18
A Phase 2 study (NEPTUNE-17) to evaluate efficacy and safety of GSK3858279 in DPNP. Ended

2022-502313-28-00 Diabetic Peripheral Neuropathic Pain 4 2023-12-14
A phase-2, multi-centre, prospective, randomized, standard-of-care plus placebo-controlled, patient and central evaluator blinded, parallel … Ended

2022-502048-10-00 diabetic foot ulcers 4 2023-07-21
A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH) Ended

2022-500101-41-00 Type 2 Diabetes 6 2023-06-07
A research study to see how well CagriSema helps people with type 2 diabetes and excess body weight lose weight Ended

2023-506931-13-00 Overweight and obesity and type 2 diabetes 5 2023-01-30
Study to evaluate the effect and the safety of ladaraxin in adult and adolescent patients with recent onset type 1 diabetes Ended

2024-513560-26-00 Recent onset Type 1 Diabetes 4 2020-12-10
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CV… Ended

2023-507846-96-00 Type 2 Diabetes Mellitus 5 2020-06-19